BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27836248)

  • 1. A review for clinicians: Prostate cancer and the antineoplastic properties of metformin.
    Hankinson SJ; Fam M; Patel NN
    Urol Oncol; 2017 Jan; 35(1):21-29. PubMed ID: 27836248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anticancer potential of metformin on prostate cancer.
    Zaidi S; Gandhi J; Joshi G; Smith NL; Khan SA
    Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):351-361. PubMed ID: 30651580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and Prostate Cancer: a New Role for an Old Drug.
    Whitburn J; Edwards CM; Sooriakumaran P
    Curr Urol Rep; 2017 Jun; 18(6):46. PubMed ID: 28444639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy.
    Richards KA; Liou JI; Cryns VL; Downs TM; Abel EJ; Jarrard DF
    J Urol; 2018 Dec; 200(6):1256-1263. PubMed ID: 29940252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin in prostate cancer: two for the price of one.
    Clements A; Gao B; Yeap SHO; Wong MKY; Ali SS; Gurney H
    Ann Oncol; 2011 Dec; 22(12):2556-2560. PubMed ID: 21421541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells.
    Ge R; Wang Z; Wu S; Zhuo Y; Otsetov AG; Cai C; Zhong W; Wu CL; Olumi AF
    Oncotarget; 2015 Oct; 6(30):28973-87. PubMed ID: 26359363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin: taking away the candy for cancer?
    Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
    Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review.
    Ahn HK; Lee YH; Koo KC
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic roles of AMPK and metformin in cancer cells.
    Choi YK; Park KG
    Mol Cells; 2013 Oct; 36(4):279-87. PubMed ID: 23794020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models.
    Morale MG; Tamura RE; Rubio IGS
    Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin as an Anticancer Agent.
    Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
    Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.
    Popovics P; Frigo DE; Schally AV; Rick FG
    Expert Opin Ther Targets; 2015 May; 19(5):617-32. PubMed ID: 25600663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; ZabiƄska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways.
    Ikhlas S; Ahmad M
    Life Sci; 2017 Sep; 185():53-62. PubMed ID: 28755883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
    An H; He L
    J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin and neoplasia: implications and indications.
    Aljada A; Mousa SA
    Pharmacol Ther; 2012 Jan; 133(1):108-15. PubMed ID: 21924289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
    Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
    Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2.
    Biernacka KM; Persad RA; Bahl A; Gillatt D; Holly JM; Perks CM
    Endocr Relat Cancer; 2017 Jan; 24(1):17-30. PubMed ID: 27754854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.
    Mitsuhashi A; Kiyokawa T; Sato Y; Shozu M
    Cancer; 2014 Oct; 120(19):2986-95. PubMed ID: 24917306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin Has a Positive Therapeutic Effect on Prostate Cancer in Patients With Type 2 Diabetes Mellitus.
    Chong RW; Vasudevan V; Zuber J; Solomon SS
    Am J Med Sci; 2016 Apr; 351(4):416-9. PubMed ID: 27079349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.